UNESCO-Listed Nandagang Wetland Launches Global Photo Contest on Migratory Birds and Wetland Conservation
Image File
Original HTML

UNESCO-Listed Nandagang Wetland Launches Global Photo Contest on Migratory Birds and Wetland Conservation

The 2026 contest, a key component of Global Wetland Week invites photographers worldwide to tell stories of wetlands and migratory birds along the East AsianâAustralasian Flyway. Nandagang Wetland lies within the UNESCO-listed Yellow SeaâBohai Gulf migratory bird sanctuary, a vital link in a flyway spanning about 22 countries.

CANGZHOU, China, Oct. 28, 2026 /PRNewswire/ -- Cangzhou International Communication Center has launched Global Wetland Week, an international campaign that uses wetlands as common ground for dialogue and cultural exchange. A key component of the campaign is the 2026 Nandagang International Wetland Photo Contest, which invites photographers and video creators around the world to share wetland stories through images and bring wider public attention to wetland conservation.

Located in Cangzhou, Hebei Province, Nandagang Wetland is part of the UNESCO World Heritage-listed Migratory Bird Sanctuaries along the Coast of Yellow Sea-Bohai Gulf of China. In recent years, more than 300 hectares of wetland have been restored. Migratory bird numbers rose from about 20,000 in 2019 to more than 150,000 in 2025, while recorded bird species increased from 268 in 2021 to 274, according to the Cangzhou Natural Resources and Planning Bureau.

Under the theme "Together for Wetlands," the contest welcomes photographs and videos about wetland landscapes, migratory birds, local communities and conservation. It is open to photographers, videographers, nature observers and young creators worldwide.

Reflecting on the inaugural edition, Ma Chaode, Assistant Resident Representative at UNDP in China, said: "Wetlands, one of the three major ecosystems, are known as the 'Kidneys of the Earth.' They have functions like provision, support, regulation and culture, and are the foundation for the sustainable development of human society. The numerous wetland ecological images collected in the event vividly show the real - life beautiful scenery of the harmonious coexistence between humans and nature. It's not only a vivid microcosm of "Beautiful China", but also a typical case for promoting global ecological civilization."

"For me, photography is a way to connect people with nature and inspire its conservation," said Mario Suárez Porras, president of AFONAS and a judge for this year's contest. "I'm excited to see creative works for this year's theme."

The contest is organized by Cangzhou International Communication Center, hosted by Xinhuanet North America, with media support from Xinhuanet Hebei Channel.

Call for Entries

- Theme: "Together for Wetlands"

- Who can enter: Photographers, videographers, nature observers and young creators worldwide

- Categories: Global Wetlands; Wetlands and Migratory Birds; People and Wetlands; Nandagang Wetland; Youth Imaging (under 28); Wetland Conservation Stories (video)

- Submission deadline: November 28, 2026

- Entry fee: Free

- How to enter: Submit at globalsouthernnews.com/ndg2026. Email submissions are available as a backup at [email protected].

- Awards and recognition: A US$1,500 Grand Prize, additional cash prizes, special awards and honorable mentions. Entries will be reviewed by a ten-member international jury.

For complete eligibility requirements, submission instructions, technical specifications and copyright terms, visit globalsouthernnews.com/ndg2026

SOURCE Cangzhou International Communication Center

Share this article

Class (B2B/B2C)
B2C
Ingest Status
Rewritten
Dedupe hash
prn_302922014
Press Eligible
Yes
Press Eligible Reason
Manuelle Prüfung nötig. Risiko: MEDIUM. Flags: ['finance', 'numbers']. Stichprobe: False
Source Name
Unknown Company
Original Summary

<p>The 2026 contest, a key component of Global Wetland Week invites photographers worldwide to tell stories of wetlands and migratory birds along the East Asian–Australasian Flyway. Nandagang Wetland lies within the UNESCO-listed Yellow Sea–Bohai Gulf migratory bird sanctuary, a vital link...</p>

Image URL
https://i.ytimg.com/vi/YTzP80uOZQY/hqdefault.jpg
Content Hash (SHA-256, erste 32 hex)
9f1d662fd75d3da9aa01202164aa53d7
Terex Reports Third Quarter 2026 Results
Image File
Original HTML

- Sales of $2.2 billion, up 58.4% on a reported basis, pro forma sales up 11.6%

- Net income of $114 million, adjusted1 net income of $171 million

- Adjusted1 EBITDA7 of $286 million or 13.0% margin

- Diluted EPS of $1.00 and adjusted1 Diluted EPS2 of $1.50

- Bookings of $2.3 billion increased 52.7% year over year on a pro forma13 basis

- Refining 2026 Outlook5: Sales of $8.0 to $8.2 billion, Adjusted1 EBITDA7 of $930 million to $960 million with 11.7% Adjusted1 EBITDA7 margin at the midpoint, and Free cash flow of $360 million to $400 million

- Board approves a new $500 million share repurchase authorization

NORWALK, Conn., Oct. 28, 2026 /PRNewswire/ -- Terex Corporation (NYSE: TEX), a global leader in specialized equipment, serving essential sectors such as emergency services, waste and recycling, utilities, and construction, today announced its results for the third quarter 2026.

CEO Commentary

"Terex delivered higher sales, adjusted EBITDA and cash flow in the third quarter versus the prior year, with solid order activity increasing across all four segments, resulting in $7 billion backlog that provides meaningful forward visibility across the portfolio. We are also making progress integrating the expanded company, capturing synergies, and applying more consistent operating discipline to improve execution and returns," Simon Meester, Terex President & CEO said.

"Over the past few months we have made good progress in the process of separating the Aerials segment, by advancing the carve-out work and moving from evaluating inbound interest to active engagement with multiple strategic counterparties. At the same time, the Aerials team remains focused on serving customers, growing the business and improving performance. Our priority is to achieve a successful outcome that maximizes value for Terex shareholders."

Third Quarter Operational and Financial Highlights

- $7.0 billion backlog increased $802 million, or 12.9% on a pro forma basis, versus the prior year, driven by increased bookings in each segment. Bookings of $2.3 billion increased 52.7% year over year on a pro forma basis and reflects a book-to-bill of 103%.

- Net sales of $2.2 billion were 58.4% higher than the third quarter of 2025 on a reported basis. Pro forma net sales grew by 11.6% year over year, driven by growth in Materials Processing ("MP"), Specialty Vehicles ("SV"), and Aerials.

- Adjusted1 EBITDA of $286 million increased on a pro forma basis by $35 million, or 13.9%, compared to the third quarter of 2025. The year-over-year change was driven by meaningful improvements in the MP and SV segments.

- Net income was $114 million, or $1.00 per diluted share, compared to $65 million, or $0.98 per diluted share, in the third quarter of 2025. Adjusted1 net income was $171 million, or $1.50 per diluted share for the third quarter of 2026, compared to $100 million, or $1.50 per diluted share, in the third quarter of 2025.

Business Segment Review

Environmental Solutions

- Net sales of $400 million were down 8.0% or $35 million year over year, primarily due to lower shipments of refuse collection vehicles ("RCVs"), partially offset by higher utilities product sales.

- Adjusted1 EBITDA was $61 million or 15.3% of net sales for the third quarter of 2026, compared to $83 million, or 19.2% of net sales in the prior year. The decrease was driven by unfavorable mix, inefficiencies related to a production ramp up in Utilities, under-absorption associated with lower refuse collection vehicle production volume and inflationary pressures.

Materials Processing

- Net sales of $434 million were up 4.1% or $17 million year over year. On a pro forma13 basis, net sales were up 11.3% year over year, driven by increased shipments across most product categories, with the largest increase coming from Aggregates in North America.

- Adjusted1 EBITDA was $84 million, or 19.3% of net sales for the third quarter of 2026, compared to the prior year of $56 million, or 13.5% of net sales and $55 million, or 14.0% of net sales, on a pro forma13 basis. The improvement was driven by higher shipment volume, favorable mix, price cost discipline, and improved absorption driven by higher production volumes.

Specialty Vehicles

- Net sales of $657 million were up 8.1% or $49 million year over year on a pro forma13 basis, driven by increased shipments of fire apparatus and recreational vehicles.

- Adjusted1 EBITDA was $105 million, or 16.0% of net sales for the third quarter of 2026, compared to $79 million, or 13.0% of net sales on a pro forma13 basis in the prior year. The increase was primarily due to operational efficiency and price cost discipline, partially offset by inflationary pressures.

Aerials

- Net sales of $709 million were up 32.0% or $172 million year over year, primarily due to higher shipment volume resulting from strong demand from national customers and increased customer capital spending on large projects.

- Adjusted1 EBITDA was $62 million, or 8.7% of net sales, for the third quarter of 2026, compared to $56 million, or 10.5% of net sales in the prior year. The change was primarily due to higher sales and cost out actions, partially offset by unfavorable customer mix, inflationary and tariff pressures.

Balance Sheet and Liquidity

- Free cash flow7 of $209 million, up $79 million from the prior year period.

- As of September 30, 2026, liquidity (cash and availability under our revolving line of credit) was $1.2 billion.

- During the third quarter of 2026, Terex deployed $32 million in capital expenditures and investments to support future business growth and operational improvements.

- During the third quarter of 2026, Terex returned $19 million to shareholders through dividends and $72 million through share repurchases, leaving approximately $111 million available for repurchase under our current share repurchase programs.

- The Board of Directors authorized a new $500 million share repurchase program, totaling $611 million available for repurchase.

CFO Commentary

"Terex delivered solid third-quarter financial performance, with pro forma sales growth of approximately 12% and pro forma adjusted EBITDA growth of 14%, reflecting higher volumes, solid operating execution and realized synergies. Improved working capital efficiency contributed to $241 million of operating cash flow and $209 million of free cash flow during the quarter. We returned $91 million to shareholders through share repurchases and dividends while reducing debt by $113 million," said Jennifer Kong-Picarello, Terex Senior Vice President and Chief Financial Officer. "The Board's new $500 million share repurchase authorization provides additional flexibility to return capital opportunistically within our balanced capital allocation framework, while maintaining the capacity to invest in the business and strengthen the balance sheet."

2026 Outlook

Based on third quarter performance, backlog visibility, and synergy realization, the company is refining its full year outlook. It expects 2026 sales to grow approximately 8.5% on a pro forma14 basis to $8.0 to $8.2 billion, Adjusted1 EBITDA to grow by approximately 10% year over year on a pro forma14 basis to between $930 million and $960 million, or 11.7% Adjusted1 EBITDA margin at the mid-point, and Free cash flow of $360 million to $400 million. The Adjusted1 Diluted EPS2 outlook of $4.80 - $5.00 includes the following assumptions/commentary:

- 11 months impact of the new Specialty Vehicle segment (former REV)

- ~$28 million of realized synergies for 2026, on-target to achieving a $75 million annual run-rate within 2 years

- Excludes the divested MP cranes and Midwest RV business results

- Current tariff rates

- Interest of ~$180 million, consistent with pro-forma 2025

- Full year effective tax rate of ~19%

- Full year average diluted shares outstanding of ~110 million for 2026, including ~113 million in Q4

Non-GAAP Measures and Other Items

Results of operations reflect continuing operations. All per share amounts are on a fully diluted basis. A comprehensive review of the quarterly financial performance is contained in the presentation that will accompany the Company's earnings conference call.

In this press release, Terex refers to various GAAP (U.S. generally accepted accounting principles) and non-GAAP financial measures. These non-GAAP measures may not be comparable to similarly titled measures being disclosed by other companies. Management believes that presenting these non-GAAP financial measures provide investors with additional analytical tools which are useful in evaluating our operating results and the ongoing performance of our underlying businesses because they (i) provide meaningful supplemental information regarding financial performance by excluding impact of one-time items and other items affecting comparability between periods, (ii) permit investors to view performance using the same tools that management uses to budget, make operating and strategic decisions, and evaluate our core operating performance across periods, and (iii) otherwise provide supplemental information that may be useful to investors in evaluating our financial results. We do not, nor do we suggest that investors, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP.

The Glossary at the end of this press release contains further details about this subject.

Conference call

The Company has scheduled a conference call to review the financial results on Wednesday, October 28, 2026 beginning at 8:30 a.m. ET. Simon A. Meester, President and CEO, and Jennifer Kong-Picarello, Senior Vice President and Chief Financial Officer, will host the call. A simultaneous webcast of this call can be accessed at https://investors.terex.com. Participants are encouraged to access the call 15 minutes prior to the starting time. The call will also be archived in the Event Archive at https://investors.terex.

Ingest Status
Rejected
Dedupe hash
prn_302921404
Source Name
Unknown Company
Original Summary

<p>Sales of $2.2 billion, up 58.4% on a reported basis, pro forma sales up 11.6% Net income of $114 million, adjusted1 net income of $171 million Adjusted1 EBITDA7 of $286 million or 13.0% margin Diluted EPS of $1.00 and adjusted1 Diluted EPS2 of $1.50 Bookings of $2.3 billion increased...</p>

Image URL
https://mmx.prnewswire.com/media/MS1552386/Logo-2024-Logo-Logo.jpg?id=OA3043275&p=facebook
Content Hash (SHA-256, erste 32 hex)
a449b4a9b8b012219e9c3c663caf7941
Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting
Image File
Original HTML

Research explores the role of TUSC2, the therapeutic gene used in Reqorsa® Gene Therapy in mitochondrial biology and cellular aging, supporting investigation of potential applications beyond oncology

AUSTIN, Texas, Oct. 28, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage biotechnology company developing gene therapies designed to restore tumor-suppressor function in cancer and insulin-producing function in diabetes, today announced that research conducted under its sponsored research collaboration with Meharry Medical College in Nashville, Tennessee will be featured at the Gerontological Society of America (GSA) 2026 Annual Scientific Meeting, taking place November 4-7, 2026, in National Harbor, Maryland.

The research investigates the role of TUSC2, the tumor suppressor gene used in Genprex's lead oncology candidate REQORSA (quaratusugene ozeplasmid, or Quar Oze), in mitochondrial biology, cellular resilience, and molecular processes associated with aging. The work contributes to an expanding understanding of TUSC2 and REQORSA biology and may help inform the evaluation of potential future therapeutic applications beyond oncology.

Genprex's Sponsored Research Collaboration with Meharry Medical College

Genprex established a sponsored research collaboration with Meharry Medical College in 2024 to investigate aspects of REQORSA biology, including mitochondrial metabolism and molecular aging and their potential relationship to cancer. The collaboration builds on the scientific rationale underlying REQORSA, which is designed to restore tumor-suppressor function through delivery of the TUSC2 gene.

Research conducted through the collaboration is examining the broader biological activities of REQORSA, including its involvement in cellular metabolism and stress-response pathways. Genprex is also working with Meharry Medical College to expand the scope of this research, with additional work intended to further investigate the role of REQORSA in aging-related biological processes.

"Through our collaboration with Meharry Medical College, we are continuing to build our understanding of the TUSC2 gene used in REQORSA and its potential relevance to biological processes beyond cancer," said Ryan Confer, President and Chief Executive Officer of Genprex. "The research into mitochondrial biology and cellular aging is particularly interesting because it may help identify opportunities for further scientific investigation. We believe this collaboration provides an important opportunity to explore the broader potential future therapeutic applications of REQORSA."

GSA 2026 Poster Presentation

Title: "TUSC2 Gene Therapy in Humans Induces a Cellular-Resilience Program"

Session Name: Late Breaking Poster Session I

Session Date: Wednesday, Nov. 4, 2026

Session Time: 6:00 -7:15 p.m. ET

Location: Gaylord National Resort & Convention Center, Exhibit Hall C-D

Abstract ID: 2489375

Presenter: Mark S. Berger, MD, Chief Medical Officer of Genprex

Exploring the Broader Potential of REQORSA

The sponsored research and collaboration with Meharry Medical College supports Genprex's continued investigation of TUSC2 and REQORSA biology and its potential relevance to aging-related processes. While additional research will be needed to determine whether these findings could support future therapeutic development, the work represents an opportunity to explore applications beyond oncology, alongside Genprex's established development priorities in lung cancer and diabetes.

The GSA poster is expected to be available on Genprex's website following the presentation, subject to applicable conference disclosure requirements.

About Genprex, Inc.

Genprex, Inc. is a clinical-stage gene therapy company focusing on developing innovative treatments designed to restore biological functions disrupted by disease. The Company's lead oncology program, REQORSA® Gene Therapy is being developed for the treatment of lung cancer and is designed to deliver the TUSC2 tumor suppressor gene to help restore tumor-suppressive activity and address multiple pathways involved in cancer progression.

The Company's lead candidate, Reqorsa® Gene Therapy (quaratusugene ozeplasmid), uses the systemic, non-viral ONCOPREX® Delivery System to deliver the TUSC2 tumor suppressor gene via a non-viral lipid-based nanoparticle. REQORSA is designed to restore tumor-suppressor function and is being evaluated in the Acclaim-1 and Acclaim-3 clinical trials for non-small cell lung cancer and small cell lung cancer, respectively. The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to both lung cancer programs and Orphan Drug designation to the small cell lung cancer program.

Genprex is also advancing an earlier stage gene therapy program for diabetes, designed to restore insulin-producing capability through the expression of key pancreatic transcription factors. Across its programs, Genprex is focused on translating innovative gene therapy approaches into meaningful therapeutic advances for patients with significant unmet medical needs.

For more information, please visit https://www.genprex.com/, register for our Email Alerts and follow us on LinkedIn, X, and Facebook.

Cautionary Language Concerning Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of management, are not guarantees of performance and are subject to significant risks and uncertainty. These forward-looking statements should, therefore, be considered in light of various important factors, including those set forth in Genprex's reports that it files from time to time with the Securities and Exchange Commission and which you should review, including those statements under "Item 1A â Risk Factors" in Genprex's Annual Report on Form 10-K for the year ended December 31, 2025.

Because forward-looking statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding: Genprex's ability to advance the clinical development, manufacturing and commercialization of its product candidates in accordance with projected timelines and specifications; the timing and success of Genprex's clinical trials, its intended regulatory submissions and any resulting regulatory approvals; the effect of Genprex's product candidates, alone and in combination with other therapies, on cancer and diabetes, as well as the potential effect in aging-related biological processes; Genprex's future growth and financial status, including Genprex's ability to maintain compliance with the continued listing requirements of The Nasdaq Capital Market and to continue as a going concern and to obtain capital to meet its long-term liquidity needs on acceptable terms, or at all; Genprex's commercial and strategic partnerships, including those with its third party vendors, suppliers and manufacturers and their ability to successfully perform and scale up the manufacture of its product candidates; Genprex's intellectual property and licenses; and Genprex's current expectations, estimates, forecasts and projections about the industry and markets in which it operates.

These forward-looking statements should not be relied upon as predictions of future events and Genprex cannot assure you that the events or circumstances discussed or reflected in these statements will be achieved or will occur. If such forward-looking statements prove to be inaccurate, the inaccuracy may be material. You should not regard these statements as a representation or warranty by Genprex or any other person that Genprex will achieve its objectives and plans in any specified timeframe, or at all. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Genprex disclaims any obligation to publicly update or release any revisions to these forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release or to reflect the occurrence of unanticipated events, except as required by law.

Genprex, Inc.

(877) 774-GNPX (4679)

GNPX Investor Relations Contact

Lisa DeScenza

[email protected] 

GNPX Media Contact

Kalyn Dabbs

[email protected] 

SOURCE Genprex, Inc.

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302921460
Press Eligible
Yes
Press Eligible Reason
Manuelle Prüfung nötig. Risiko: HIGH. Flags: ['medical']. Stichprobe: False
Source Name
Unknown Company
Original Summary

<p>Research explores the role of TUSC2, the therapeutic gene used in Reqorsa® Gene Therapy in mitochondrial biology and cellular aging, supporting investigation of potential applications beyond oncology AUSTIN, Texas, Oct. 28, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company")...</p>

Image URL
https://mmx.prnewswire.com/media/MS607668/Genprex-2-Logo.jpg?id=OA3043603&p=facebook
Content Hash (SHA-256, erste 32 hex)
a2af65c9bc77d633cd242bbbea030e81
The Farmer's Dog Unleashes a Fresh Take on College Sports' NIL Era with Five All-Star Live Mascots
Image File
Original HTML

The Farmer's Dog to celebrate UGA's Uga, Tennessee's Smokey, UConn's Jonathan, Tulsa's Goldie and Washington's Dubs, the beloved real dog mascots that are icons of their campus communities

NEW YORK, Oct. 28, 2026 /PRNewswire/ -- College sports' NIL era has produced deals for quarterbacks, point guards and some of the biggest names in college athletics. Now, the dogs are getting in on it.

The Farmer's Dog®, the leader in real, human-grade dog food, today announced partnerships with Georgia, Tennessee, UConn, Tulsa and Washington including their beloved live college dog mascots as the stars of the show: Uga of Georgia, Smokey of Tennessee, Jonathan of UConn, Goldie of Tulsa and Dubs of Washington.

The five dogs are among the most recognizable figures on their campuses. They lead teams onto the field, patrol the sidelines, pose with generations of fans and represent traditions that stretch back decades. The partnership officially brings The Farmer's Dog into that tradition as the pet food partner of all five athletic departments for the next three years. Through this partnership, The Farmer's Dog will help care for the dogs who give so much to their communities by providing them with real, human-grade meals and treats.

"The Farmer's Dog building connections with these five schools in particular just makes sense and complements the fandom that already exists with the iconic mascots at each university," said Shawn Hegan, Executive Vice President of Global Partnerships at Learfield. "We're glad to bring these partners together and create an opportunity for The Farmer's Dog to become part of traditions that already mean a lot to students, alumni and passionate college sports fans."

Meet the Class of Canines

- Uga XI | University of Georgia Bulldogs: One of the most recognizable mascots in college sports, Uga XI (aka Boom) is the latest in the University of Georgia's beloved line of live English bulldog mascots, carrying on a tradition that began with Uga I in 1956.

- Smokey | University of Tennessee Vols: The Bluetick Coonhound is a fixture of game day in Knoxville, leading the Vols through the Power T and carrying on a mascot tradition more than 70 years strong.

- Jonathan | University of Connecticut Huskies: A staple of UConn life from move-in day through graduation since Jonathan I made his debut in 1924. Today, three-year-old Jonathan XV, often joined by his older brother Jonathan XIV, represents the Huskies on campus and at some of the biggest moments in UConn sports.

- Goldie | University of Tulsa Golden Hurricane: The Golden Retriever is beginning her "freshman" year at Tulsa and will spend the next four years growing up alongside the Class of 2030.

- Dubs | University of Washington Huskies: The eight-year-old Alaskan Malamute carries on a tradition dating back to 1922, leading the Huskies onto the field before every home game. He was named 2025 Mascot of the Year by the Seattle Sports Commission.

Fans will also see the newest members of The Farmer's Dog roster throughout the season through game-day experiences, in-stadium promotions, athlete collaborations and tailgate activations spanning football, men's and women's basketball, baseball and softball. At each school, student-athletes will collaborate with The Farmer's Dog to create content featuring the school's live mascot, giving fans a behind-the-scenes look at the dogs and their personalities while connecting the brand with some of the most recognizable traditions on each campus. As The Farmer's Dog expands its presence in college sports, Altius Sports Partners is advising the brand on its collegiate strategy and working alongside Learfield on the multi-school partnership.

The Farmer's Dog's connection to college athletics also extends beyond game day. At Georgia and Tennessee, the company funds residencies for small animal veterinary nutrition that help train the next generation of Board-Certified Veterinary Nutritionists® and advance the understanding of canine nutrition.

The five dogs join a growing sports roster for The Farmer's Dog that includes the National Football League (NFL), New York Giants running back Cam Skattebo, U.S. tennis star Jess Pegula, and NASCAR champion Ryan Blaney, who share in the same belief in doing the best we can for our dogs.

Fans can learn more and follow the newest at http://thefarmersdog.com/mascots.

About The Farmer's Dog: For more than a decade, The Farmer's Dog has been setting a higher bar for pet care by providing freshly cooked and minimally processed meal plans designed to help dogs live longer, healthier lives. Our on-staff team of Board-Certified Veterinary Nutritionists®, PhD nutritionists, and veterinarians work to develop recipes packed with the nutrients dogs need, while avoiding the downsides of excess processing. Every meal is complete and balanced, made to human-grade safety standards, and delivered directly to customers' doors. For more information, visit thefarmersdog.com and follow on social media: @thefarmersdog. Contact: [email protected]

About Learfield: Learfield is the leading media and technology company powering college athletics. Through its digital and physical platforms, Learfield owns and leverages a deep data set and relationships in the industry to drive revenue, growth, brand awareness, and fan engagement for brands, sports, and entertainment properties. With ties to over 1,200 collegiate institutions and over 12,000 local and national brand partners, Learfield's presence in college sports and live events delivers influence and maximizes reach to target audiences. With solutions for a 365-day, 24/7 fan experience, Learfield enables schools and brands to connect with fans through licensed merchandise, game ticketing, donor identification for athletic programs, exclusive custom content, innovative revenue generation solutions, student-athlete marketing initiatives, and advanced digital platforms. Since 2008, it has served as title sponsor for the acclaimed Learfield Directors' Cup, supporting athletic departments across all divisions.

Media Contact: [email protected]

SOURCE The Farmer's Dog

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302921556
Press Eligible
Yes
Press Eligible Reason
Company partnership announcement involving college athletics, sponsorships, and brand activations.
Source Name
Unknown Company
Original Summary

<p>The Farmer's Dog to celebrate UGA's Uga, Tennessee's Smokey, UConn's Jonathan, Tulsa's Goldie and Washington's Dubs, the beloved real dog mascots that are icons of their campus communities NEW YORK, Oct. 28, 2026 /PRNewswire/ -- College sports' NIL era has produced deals for quarterbacks,...</p>

Image URL
https://mmx.prnewswire.com/media/MS2022299/The-Farmer-s-Dog-Image.jpg?id=OA3043671&p=facebook
Content Hash (SHA-256, erste 32 hex)
fa4eb077a8670de09631c180fb903223
Scott Zack's Creek Equity Details Healthcare Services Portfolio Spanning Supply Chain, Pharmacy Benefits, and Medical Courier Logistics
Image File
Original HTML

Bloomfield Hills investment company's operating businesses serve hospitals, health systems, laboratories, employers, and benefit funds across Michigan and beyond.

BLOOMFIELD HILLS, Mich., Oct. 28, 2026 /PRNewswire/ -- Creek Equity, the private investment company founded and owned by investor and entrepreneur Scott Zack, today detailed the portfolio of healthcare services companies it has built and backed, which now spans healthcare supply chain, pharmacy benefit management, and medical courier logistics.

Creek Equity founds companies, backs founders with early capital, and acquires established businesses, investing its own capital and holding for the long term.

"Healthcare wastes enormous money between the people who pay and the people who deliver care," said Zack, Founder and Owner of Creek Equity. "Each of our companies fixes one piece: what hospitals buy, what plans pay for drugs, and how specimens get from clinic to lab."

The portfolio includes Avenix Medical Group, a healthcare supply chain partner providing strategic sourcing, supplier visibility, risk monitoring, and continuity planning for hospitals, health systems, physician groups, and post-acute care; Movanti Group, a transparent, 100 percent pass-through pharmacy benefit manager for employers, unions, and benefit funds; Total Routing Solutions, a medical courier providing specimen pickup and delivery for clinical laboratories and other healthcare companies; and Avenix Solutions Group, a procurement-optimization partner for automotive, healthcare, and hospitality. Creek Equity also owns Blue Cypress, its real estate arm, and Creek Equity Advisors, its advisory affiliate

Creek Equity typically holds majority or founding positions and works directly with management on operations, procurement, and growth. Its full portfolio and Investment Principles are published at https://www.creekequity.com.

About Creek Equity

Creek Equity is a private investment company in Bloomfield Hills, Michigan, owned by Scott Zack, that founds, funds, and acquires businesses across healthcare services, supply chain, logistics, and real estate. The firm invests its own capital and holds for the long term. Creek Equity is a BBB Accredited Business with an A+ rating.

About Scott Zack

Scott Zack is an investor and entrepreneur based in Bloomfield Hills, Michigan, and the Founder and Owner of Creek Equity. A former basketball player at The Ohio State University, he has founded, acquired, operated, and sold businesses in healthcare, supply chain, construction, and real estate.

Media Contact: Scott Zack, [email protected]

"Press Release Service" should be linked to https://www.24-7pressrelease.com/.

SOURCE Creek Equity

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302921708
Press Eligible
Yes
Press Eligible Reason
Business news about an investment company’s healthcare services portfolio.
Source Name
Unknown Company
Original Summary

<p>Bloomfield Hills investment company's operating businesses serve hospitals, health systems, laboratories, employers, and benefit funds across Michigan and beyond. BLOOMFIELD HILLS, Mich., Oct. 28, 2026 /PRNewswire/ -- Creek Equity, the private investment company founded and owned by...</p>

Image URL
https://mmx.prnewswire.com/media/MS2022322/Creek-Equity-logo.jpg?id=OA3043723&p=facebook
Content Hash (SHA-256, erste 32 hex)
1771ea7f84a586ca3da56dce68ee912a
Greece Sotheby's International Realty: More than €200 million of completed sales in the Ionian, including the two highest sales ever recorded in Corfu
Image File
Original HTML

â Closed-transaction data, rather than asking prices, published for the first time for the prime and super-prime residential market of Corfu, Paxos, Lefkada and Kefalonia

ATHENS, Greece, Oct. 28, 2026 /PRNewswire/ -- Greece Sotheby's International Realty today publishes The Prime and Super-Prime Ionian Property Market, a report drawn exclusively from the completed sales the firm has brokered on the four Ionian islands since 2018: more than â¬200 million in total, with six sales above â¬10 million.

In Corfu the firm has completed sales worth â¬138.3 million, five of them above â¬10 million, the largest body of completed prime and super-prime transactions held by any brokerage on the island. The record includes the two highest residential sales ever recorded in Corfu: a property at Kassiopi, sold in 2024 for more than â¬15 million, and a property at Nissaki, sold in 2026 for between â¬14 and â¬15 million. On Paxos, the three highest prices ever paid on the island, the first just above â¬5 million, were completed by the firm's team, and in Lefkada and Kefalonia the firm's track record includes the highest-value sale on each island; the Lefkada sale, of a property at around â¬11 million, was completed in 2024 by the firm's Private Office.

What the completed transactions show

The report analyses sales of â¬1 million and above on the basis of medians. The median sale price in the Ionian is â¬2.4 million, and â¬3.0 million in Corfu, for a home of five or six bedrooms.

Price per square metre rises with price: around â¬5,900 per m² for sales of â¬1â2 million, â¬8,500 for sales of â¬2â5 million and â¬10,900 above â¬5 million. The homes that sell above â¬5 million are, almost without exception, on the water; at that level buyers are paying, above all, for scarcity. Prices per square metre start at around â¬4,000 and reach above â¬23,000 for a waterfront house on Paxos, while the highest figure in Corfu exceeds â¬15,500 per m².

The median agreed price was 9 per cent below the asking price. More than half of the homes sold within 10 per cent of the asking price and one in eight at the full asking price. The gap is narrower, at about 5 per cent, on Paxos and in the â¬1â2 million band, where comparable sales are plentiful, and wider in the younger markets of Lefkada and Kefalonia, where asking prices are still often exploratory.

The median time from listing to agreement is nine months, and completion takes a further five. The decision itself is quick: from the first viewing to an agreement the median is under three weeks.

British buyers account for 56 per cent of sales and 56 per cent of their value, with Germans second at 15 per cent and fourteen nationalities in all. The median buyer is 53 years old, and most buy for family use rather than for yield.

Comment

Spyros Analytis, Head of Sales for the Ionian at Greece Sotheby's International Realty, born and raised in Corfu and with more than 35 years in the island's property market, said: "The measure of a firm in Corfu is the value it has actually closed. We are publishing these figures because a market that runs on asking prices and hearsay serves neither the seller nor the buyer. Closed figures serve both. An asking price that reflects reality establishes serious and inviting ground for the discussion between the two sides, and a property that sits on the market for a long time can affect its reputation and, in the end, its value."

Savvas Savvaidis, President and CEO of Greece Sotheby's International Realty, said: "The Ionian has the oldest tradition of foreign ownership in Greece and one of the most mature prime residential markets in the Mediterranean. By publishing our completed transactions we give owners and buyers what they have lacked: evidence. Our record across the four islands, including the highest sales ever recorded in Corfu and on Paxos, is the result of exactly this approach: pricing from real data and respect for the time of both parties."

The full report and the interview with Spyros Analytis are published on the Intelligence Hub, the Research & Market Intelligence section of sothebysrealty.gr.

Methodology

The figures are drawn from the completed sales brokered by Greece Sotheby's International Realty in Corfu, Paxos, Lefkada and Kefalonia between 2018 and October 2026, worth â¬200.8 million in total, of which â¬138.3 million in Corfu. Sizes, prices per square metre, timings and discounts to asking price are medians, rounded, over sales of â¬1 million and above. No individual property or client is identified.

Media information

About Greece Sotheby's International Realty

Greece Sotheby's International Realty has represented the Sotheby's International Realty network in Greece since 2016 and specialises in the prime and super-prime residential market, with offices in Athens, Corfu, Mykonos and Thessaloniki. The firm's Private Office handles its most significant transactions across Greece. Through the Sotheby's International Realty network the firm works with offices in more than 80 countries, which frequently introduce either the seller or the buyer.

SOURCE Greece Sotheby's International Realty

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302921152
Press Eligible
Yes
Press Eligible Reason
Manuelle Prüfung nötig. Risiko: MEDIUM. Flags: ['finance', 'numbers']. Stichprobe: False
Source Name
Greece Sotheby's International Realty
Original Summary

<p>● Closed-transaction data, rather than asking prices, published for the first time for the prime and super-prime residential market of Corfu, Paxos, Lefkada and Kefalonia ATHENS, Greece, Oct. 28, 2026 /PRNewswire/ -- Greece Sotheby's International Realty today publishes The Prime and...</p>

Image URL
https://mmx.prnewswire.com/media/MS2021813/Corfu.jpg?id=OA3042372&p=facebook
Content Hash (SHA-256, erste 32 hex)
00ae5fdeadb5784deba28a0ac8471ff0
Dechra Releases 2026 Sustainability Report
Image File
Original HTML

Highlights commitments and progress toward creating sustainable, long-term value for animals, people and the planet

BOSTON, Oct. 28, 2026 /PRNewswire/ -- Dechra, a global leader in veterinary specialty care, today released its 2026 Sustainability Report, outlining its progress and commitments to animals, people, communities and the planet. By delivering evidence-based sustainable innovation, reducing environmental impacts and creating positive, social outcomes for people and pets, Dechra is advancing animal health responsibly and sustainably.

"For Dechra, sustainability is about the long-term health of our business, planet and the animals we care for," said Jesper Nordengaard, Dechra CEO. "As a global animal health company, we have a responsibility to operate thoughtfully, from how we develop and manufacture our products, to how we support our people and communities. It's not separate from our strategy; it's part of how we create lasting value and make a positive difference for generations to come."

How Dechra is driving impact for animals and humans globally

The report centers on four interconnected principles in Dechra's Sustainability Strategy: Sustainable Innovation, Resilient Planet, Thriving People and Strong Communities.

As part of its commitment to Sustainable Innovation, in fiscal 2026 Dechra invested 9.6% of revenue globally in research and development (R&D) to support the development of evidence-based animal health solutions and used sustainable sources1 for more than 98% of paper-based product packaging. In building a Resilient Planet, Dechra has reduced its Scope 1 and 2 greenhouse gas emissions by 27% since its baseline year and recycled, reused or recovered 98% of waste2.

As part of its Thriving People initiative, Dechra offers Dechra Academy in 40 countries where employees accrued 33,785 hours of learning. In fostering Strong Communities, Dechra has donated £330,000 for community and charitable initiatives across 28 countries, awarded £45,000 in veterinary scholarships and logged 4,200 employee volunteer hours across 18 countries.

Dechra's strategy is rooted in four principles across its value chain:

- Sustainable Innovation: By integrating sustainability considerations into research, development and product stewardship, Dechra aims to deliver solutions that support animal wellbeing and advance animal health, while creating long-term value for customers, stakeholders and society.

- Resilient Planet: Through responsible resource management, climate action and environmental stewardship, Dechra utilizes sustainable practices across its product supply chain to reduce its environmental impact.

- Thriving People: By investing in the wellbeing, capability and long-term growth of its people, Dechra creates a safe, inclusive environment for its employees to thrive and for veterinary professionals to deliver the best outcomes for animals in their care.

- Strong Communities: Through partnerships, volunteering, charitable initiatives and responsible business processes, Dechra is focused on creating positive social value in the communities it operates.

"At Dechra, our commitment to sustainability is central to our strategy, shaping decisions across the business that help us build resilience, drive performance and deliver lasting value," said Christopher Tickner, Ph.D., Senior Director, Health, Safety and Sustainability. "As the challenges facing society continue to evolve, so too will our approach. Ultimately, it is those collective actions â large and small â that ensure our difference makes a difference."

What's Next in Dechra's Sustainability Journey

In the years ahead, Dechra plans to introduce nature metrics, expand efforts to strengthen the human-animal bond in communities around the world and reduce Scope 3 emissions from anesthetic gases. From product development to people and culture, Dechra plans to continue activating practices that drive sustainable results across the enterprise, while delivering near-term Science Based Targets initiative (SBTi) targets across its value chain.

For more information on Dechra's 2026 Sustainability Report, view the full report here: www.dechra.com/sustainability

About Dechra

Dechra is a global specialist in veterinary pharmaceuticals and related products. The company focuses on the development, manufacturing, and marketing of high-quality veterinary products to support animal health and welfare worldwide. For more information, visit www.dechra.com.

Media Contact:   

Lauren Dorsch, VP, Corporate Affairs and Commercial Communications

913-914-6903 

[email protected]   

www.dechra.com

References

1. Forest Stewardship Council (FSC), Programme for the Endorsement of Forest C

2. Includes incineration with heat recovery, composting, anaerobic digestion and solvent recovery

SOURCE Dechra

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302921253
Press Eligible
Yes
Press Eligible Reason
Manuelle Prüfung nötig. Risiko: MEDIUM. Flags: ['finance', 'numbers']. Stichprobe: False
Source Name
Unknown Company
Original Summary

<p>Highlights commitments and progress toward creating sustainable, long-term value for animals, people and the planet BOSTON, Oct. 28, 2026 /PRNewswire/ -- Dechra, a global leader in veterinary specialty care, today released its 2026 Sustainability Report, outlining its progress and...</p>

Image URL
https://mmx.prnewswire.com/media/MS1975511/Dechra_Logo_RGB.jpg?id=OA3041960&p=facebook
Content Hash (SHA-256, erste 32 hex)
a15e77109995cf2bbf2009eb122bb75c
Grounded Lithium Files National Instrument 43-101 Compliant Pre-Feasibility Study for the Kindersley Lithium Project
Image File
Original HTML

Rigorous Technical Evaluation Frames Potential Commercial Planning

CALGARY, AB, Oct. 28, 2026 /PRNewswire/ -- (TSXV: GRD) (OTC: GRDAF) â Grounded Lithium Corp. ("GLC" or the "Company") is pleased to announce the filing of the pre-feasibility study prepared by Stantec Consulting Ltd ("Stantec") titled "NI 43-101 Technical Report: Kindersley Lithium Project â Phase 1 Pre-Feasibility Study" dated June 26, 2026, (the "PFS"), further to our news release dated October 13, 2026. The PFS was prepared for both GLC and our project partner Denison Mines Corp. ("Denison"). The PFS is available on www.sedarplus.com and on the Company's website at www.groundedlithium.com.

The PFS addresses the first phase of many for potential development of the KLP. In the opinion of the KLP project partners, this PFS represents a fulsome and honest pioneering approach in the lithium from brine industry in Canada that has the technical rigour necessary to bring potential projects of this nature to a commercial scale. Thousands of hours were incurred by representatives of the partner group in addition to representatives of Stantec and several other external third-party experts. This report provides to the marketplace what the Company and Denison believe to be a defendable project grounded in intellectual honesty and integrity. Further to the October 13, 2026 release, a few specific points to highlight include:

- Lack of impurities in the resource â as has been previously communicated in our public filings and presentations, the KLP lacks impurities related to field legacy or adjacent oil and gas deposits as compared to others in the industry. This affords the KLP a major advantage in processing flowsheets and capital preservation as other projects must deal with these specific contaminants prior to lithium extraction;

- Depth of reservoir â drilling depth correlates directly with capital costs. The KLP represents one of the shallowest resources (approximately 900 to 1,200 meters depth) in the industry which taken in isolation, results in a better capital efficiency compared to most peers on individual well development drilling capital;

- Our Reserves assessment provides increased assurance of production performance provided by in-depth reservoir modelling over 25 years to estimate produced volumes from individual wells, reinjection of spent brines for production maintenance and eventually realizing minor dilution of the brine. After 25 years of production, the PFS estimates still remaining Measured and Indicated Resources within the KLP area; and

- Scalability â the project partners are taking a cautious approach to the overall project development. This initial project phase described in the PFS accounts for only 13% of the overall KLP area and yields positive project economics. Planned activities over the short to medium term will provide additional justification to assess other phases to follow. It is contemplated that these future phases may involve enhanced returns as we apply learnings, enjoy economies of scale, and incorporate optimizations to the development.

About Grounded Lithium Corp.

GLC is a publicly traded company whose main focus is the development of the Kindersley Lithium Project in conjunction with its project partner, Denison Mines Corp. The KLP encompasses a resource base of approximately 1.0 million metric tonnes of combined Mineral Reserves and Measured and Indicated Resources of lithium carbonate equivalent. The KLP's pre-feasibility study reports a NPV8 of C$125 million and an after-tax IRR of 11%, on a considerably smaller land base than that included in the 2023 PEA. Denison has the option to earn up to a 75% working interest in the KLP by funding in aggregate up to $15,150,000 comprised of both cash payments to GLC of up to $3,150,000 and funding project expenditures of up to $12,000,000 through a structured earn-in option. In addition to the KLP, the Company also develops oil and gas resources to supplement working capital to provide a diversified asset base.

GLC's multi-faceted business model involves the consolidation, delineation, exploitation and ultimately development of our opportunity base to fulfill our vision to build a best-in-class, environmentally responsible, Canadian lithium producer supporting the global energy transition shift. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on https://www.otcmarkets.com/.

Qualified Person

Scientific and technical information contained in this press release has been prepared under the supervision of Doug Ashton, P.Eng., of Sproule International Limited and Derek Loveday, P.Geo., Vining Wolff, P.Eng., and Karen Mathers, P.Geo., of Stantec Consulting Ltd., each of whom is a qualified person within the meaning of NI 43-101.

Forward-Looking Statements

This press release may contain forward-looking statements and forward-looking information within the meaning of applicable Canadian securities laws (collectively, "forward-looking statements"). These statements are made as of the date of this press release and the fact that this press release remains available does not constitute a representation by GLC that the Company believes these forward-looking statements continue to be true as of any subsequent date. Such statements include, but are not limited to, statements pertaining to the results of the PFS; the PFS having the technical rigour necessary to bring projects of this nature to commercial scale; statements pertaining to capital efficiency and advantages to process flowsheets as compared to peers; remaining Measured and Indicated Resources after 25 years of production; planned activities over the short to medium term and the potential assessment and development of additional phases of the KLP; future phases of the KLP yielding higher project economics due to certain forecasted benefits; and the Company's vision of becoming a best-in-class, environmentally responsible Canadian lithium producer supporting the global energy transition.

Forward-looking statements are based on a number of assumptions, including, without limitation, assumptions regarding the accuracy of the PFS and the technical and economic conclusions contained therein; the accuracy of Mineral Resource and Mineral Reserve estimates; the ability to convert Inferred Mineral Resources into higher-confidence resource categories through future drilling and evaluation programs; the ability of the Company and Denison to continue advancing the KLP; the availability of equipment, services, infrastructure and personnel; the performance and suitability of selected DLE technologies; commodity prices, capital costs, operating costs and exchange rates; the ability to obtain required regulatory approvals, permits and authorizations; and the Company's ability to execute on its development plans for the KLP. Although GLC believes that the assumptions underlying, and expectations reflected in, these forward-looking statements are reasonable, it can give no assurance that these assumptions and expectations will prove to be correct.

Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such statements, including risks relating to the assumptions underlying the PFS not being realized; uncertainties inherent in Mineral Resource and Mineral Reserve estimates; changes in commodity prices, capital costs, operating costs and economic conditions; risks associated with mineral exploration, development and technical studies; risks relating to the evaluation, selection, scaling and implementation of DLE technologies; the inability to convert Inferred Mineral Resources into higher-confidence resource categories; the possibility that future drilling, delineation work or technical studies do not result in increases to Mineral Resources or Mineral Reserves or otherwise improve project economics; regulatory, permitting, environmental and Indigenous consultation risks; financing risks; and risks relating to the Company's ability to advance the KLP with Denison. GLC's forward-looking statements are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained in this press release are made as of the date hereof, and the Company does not undertake any obligation to update or revise any forward-looking statements, except as required by applicable securities laws.

This news release shall not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE Grounded Lithium Corp.

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302921715
Press Eligible
Yes
Press Eligible Reason
Manuelle Prüfung nötig. Risiko: MEDIUM. Flags: ['finance', 'numbers']. Stichprobe: False
Source Name
Unknown Company
Original Summary

<p>Rigorous Technical Evaluation Frames Potential Commercial Planning CALGARY, AB, Oct. 28, 2026 /PRNewswire/ -- (TSXV: GRD) (OTC: GRDAF) – Grounded Lithium Corp. ("GLC" or the "Company") is pleased to announce the filing of the pre-feasibility study prepared by Stantec Consulting Ltd...</p>

Image URL
https://mmx.prnewswire.com/media/MS1327677/Grounded-Lithium-Corp-Grounded-Lithium-Files-National-Instrumen.jpg?id=OA3043631&p=facebook
Content Hash (SHA-256, erste 32 hex)
a62892ba449fa6f89669d9621f72ef1e
Kraton Appoints Brian Rea as Chief Human Resources Officer
Image File
Original HTML

HOUSTON, Oct. 28, 2026 /PRNewswire/ -- Kraton Corporation, a leading global producer of specialty polymers and high-value bio-based chemicals derived from pine wood pulping byproducts, announces the appointment of Brian Rea as Chief Human Resources Officer (CHRO).

"We are excited to welcome Brian to Kraton's executive leadership team," said Romi Yoon, Katon's Chief Strategy Officer. "His extensive experience leading human resources across global manufacturing organizations makes him a great fit for Kraton. I look forward to his contributions as we continue to strengthen our organization and position Kraton for the future."

Rea brings extensive global human resources experience to Kraton, having held CHRO and other leadership roles with several international, multi-site manufacturing businesses. Throughout his career, he has led a broad range of HR disciplines, including talent and succession planning, organizational transformation, labor relations, employee engagement, safety, and change leadership.

"I am excited to join Kraton and work alongside its immensely talented global team," said Rea. "I look forward to helping further shape the culture, strategy, and goals that will lead Kraton into the future. I am grateful to the Kraton leadership team for the opportunity to serve our employees."

Rea's appointment reinforces Kraton's commitment to the growth and well-being of its people and to building an organization positioned for long-term success.

About Kraton Corporation

Kraton Corporation is a leading global producer of specialty polymers and high-value performance products derived from renewable resources. Kraton's polymers are used in a wide range of applications, including adhesives, coatings, consumer and personal care products, sealants, and lubricants, and medical, packaging, automotive, paving and roofing products. As the largest global provider in the pine chemicals industry, the company's pine-based specialty products are sold into adhesive, road and construction and tire markets, and it produces and sells a broad range of performance chemicals into markets that include fuel additives, oilfield chemicals, coatings, metalworking fluids and lubricants, inks, and mining. Kraton offers its products to a diverse customer base in over 70 countries worldwide.

*Kraton, the Kraton logo and design are all trademarks of Kraton Corporation, or its subsidiaries or affiliates, in one or more, but not all countries.

Media Contact: Amanda Lubow, [email protected]

SOURCE Kraton Corporation

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302919402
Press Eligible
Yes
Press Eligible Reason
Corporate executive appointment at a specialty chemicals manufacturer.
Source Name
Unknown Company
Original Summary

<p>HOUSTON, Oct. 28, 2026 /PRNewswire/ -- Kraton Corporation, a leading global producer of specialty polymers and high-value bio-based chemicals derived from pine wood pulping byproducts, announces the appointment of Brian Rea as Chief Human Resources Officer (CHRO). "We are excited to...</p>

Image URL
https://mmx.prnewswire.com/media/MS2020013/Kraton-Corporation-Brian-Rea-photo.jpg?id=OA3037655&p=facebook
Content Hash (SHA-256, erste 32 hex)
c7961086374dee21f9932223b889f4e9
OGE Energy Corp. reports third quarter 2026 results
Original HTML

OGE Energy Corp. reports third quarter 2026 results

OKLAHOMA CITY, Oct. 28, 2026 /PRNewswire/ -- OGE Energy Corp. (NYSE: OGE), the parent company of Oklahoma Gas and Electric Company ("OG&E"), today reported earnings of $1.52 per diluted share during the three months that ended September 30, 2026, compared to $1.14 per diluted share in the third quarter 2025.

- OG&E, a regulated electric company, contributed earnings of $1.54 per diluted share in the third quarter, compared to earnings of $1.20 per diluted share in the third quarter 2025.

- Other operations, which includes the holding company, contributed a loss of $0.02 per diluted share compared to a loss of $0.06 per diluted share in the third quarter of 2025.

"I'm proud of our team for delivering reliable service through record-setting weather conditions while continuing to execute on investments that strengthen the grid and position us to support future growth across our region," said Sean Trauschke, Chairman, President and CEO of OGE Energy Corp.

Third Quarter 2026 results

OG&E contributed net income of $320.9 million, or $1.54 per diluted share, in the third quarter compared to $242.9 million, or $1.20 per diluted share, in the same period 2025. The increase in net income was driven by stronger sales from significantly warmer weather, partially offset by increased income tax expense.

Other Operations resulted in a loss of $4.7 million, or $0.02 per diluted share, in the third quarter compared to a loss of $11.6 million, or $0.06 per diluted share, in the same period 2025. Results were driven by higher income from energy-related investments and lower interest expense.

OGE Energy's net income was $316.2 million or $1.52 per diluted share in the third quarter, compared to earnings of $231.3 million, or $1.14 per diluted share, in the same period 2025.

2026 Outlook

Due to warmer than normal weather, OGE Energy expects to exceed its original 2026 earnings guidance range. OGE Energy now expects consolidated earnings between $2.62 to $2.68 per average diluted share. The guidance assumes, among other things, normal weather for the remainder of the year. OG&E has significant seasonality in its earnings due to weather on a year-over-year basis.

See OGE Energy's 2025 Form 10-K for other key factors and assumptions underlying its 2026 guidance.

Conference Call Webcast

OGE Energy Corp. will host an earnings and business update conference call on Wednesday, October 28, 2026, at 8 a.m. CDT. The conference will be available through the Investor Center at www.oge.com.

Some of the matters discussed in this news release may contain forward looking statements that are subject to certain risks, uncertainties and assumptions. Such forward-looking statements are intended to be identified in this document by the words "anticipate," "believe," "estimate," "expect," "forecast," "intend," "objective," "plan," "possible," "potential," "project," "target" and similar expressions. Actual results may vary materially. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to: general economic conditions, including the availability of credit, access to existing lines of credit, access to the commercial paper markets, actions of rating agencies and inflation rates, and their impact on capital expenditures; the ability of the Company to access the capital markets and obtain financing on favorable terms, as well as inflation rates and monetary fluctuations; the ability to obtain timely and sufficient rate relief to allow for recovery of items such as capital expenditures, fuel and purchased power costs, operating costs, transmission costs and deferred expenditures; prices and availability of electricity, coal and natural gas; competitive factors, including the extent and timing of the entry of additional competition in the markets served by the Company, potentially through deregulation; the impact on demand for the Company's services resulting from cost-competitive advances in technology, such as distributed electricity generation and customer energy efficiency programs; technological developments, changing markets and other factors that result in competitive disadvantages and create the potential for impairment of existing assets; factors affecting utility operations such as unusual weather conditions; catastrophic weather-related damage; unscheduled generation outages; unusual maintenance or repairs; unanticipated changes to fossil fuel, natural gas or coal supply costs or availability due to higher demand, shortages, transportation problems or other developments; environmental incidents; or electric transmission or gas pipeline system constraints; availability and prices of raw materials and equipment for current and future construction projects; the effect of retroactive pricing of transactions in the SPP markets, adjustments in market pricing mechanisms by the SPP, or allocation of transmission upgrade costs; federal or state legislation and regulatory decisions and initiatives that affect cost and investment recovery, have an impact on rate structures or affect the speed and degree to which competition enters the Company's markets; environmental laws, safety laws or other regulations that may impact the cost of operations, restrict or change the way the Company's facilities are operated or result in stranded assets; the ability of the Company to meet future capacity requirements mandated by the SPP, which could be impacted by future load growth, environmental regulations, and the availability of resources; changes in accounting standards, rules or guidelines; the discontinuance of accounting principles for certain types of rate-regulated activities; the cost of protecting assets against, or damage due to, terrorism or cyberattacks, including the Company losing control of its assets and potential ransoms, and other catastrophic events; the availability, cost, coverage and terms of insurance; changes in the use, perception or regulation of generative artificial intelligence technologies, which could limit the Company's ability to utilize such technology, create risk of enhanced regulatory scrutiny, generate uncertainty around intellectual property ownership, licensing or use, or which could otherwise result in risk of damage to the Company's business, reputation or financial results; creditworthiness of suppliers, customers and other contractual parties, including large, new customers from industries such as cryptocurrency and data centers; social attitudes regarding the electric utility and power industries; identification of suitable investment opportunities to enhance shareholder returns and achieve long-term financial objectives through business acquisitions and divestitures; increased pension and healthcare costs; national and global events that could adversely affect and/or exacerbate macroeconomic conditions, including inflationary pressures, interest rate fluctuations, supply chain disruptions, economic recessions, pandemic health events, tariffs and uncertainty surrounding continued hostilities or sustained military campaigns, and their collateral consequences; costs and other effects of legal and administrative proceedings, settlements, investigations, claims and matters, including, but not limited to, those described in the Company's Form 10-Q for the quarter ended September 30, 2026; and other risk factors listed in the reports filed by the Company with the Securities and Exchange Commission, including those listed within the Company's most recent Form 10-K for the year ended December 31, 2025.

Note: Condensed Consolidated Statements of Income for OGE Energy Corp., Condensed Statements of Income and Comprehensive Income for Oklahoma Gas & Electric Company, and Financial and Statistical Data for Oklahoma Gas & Electric Company attached.

SOURCE OGE Energy Corp.

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302921314
Press Eligible
Yes
Press Eligible Reason
Manuelle Prüfung nötig. Risiko: MEDIUM. Flags: ['finance', 'numbers']. Stichprobe: False
Source Name
Unknown Company
Original Summary

<p>OKLAHOMA CITY, Oct. 28, 2026 /PRNewswire/ -- OGE Energy Corp. (NYSE: OGE), the parent company of Oklahoma Gas and Electric Company ("OG&amp;E"), today reported earnings of $1.52 per diluted share during the three months that ended September 30, 2026, compared to $1.14 per diluted share in the...</p>

Content Hash (SHA-256, erste 32 hex)
4f241671b23607b839c6baaf38097d72